Table 3.
Study name (n) | Anterior (%) | Posterior (%) | Panuveitis (%) | Intermediate (%) |
---|---|---|---|---|
Lebanon 2014 (n = 18) [21] | 9 (50) | 1 (5.5) | 8 (4.5) | 0 |
UK 1994 (71) [20] | 44 (62) | 7 (9.9) | 14 (19.7) | 6 (8.5) |
Saudi Arabia 2009 (n = 50) [26] | 39 (78) | 2 (4) | 5 (10) | 4 (8) |
Finland 1994 (n = 191) [18] | 187 (97.9) | 1 (0.1) | 2 (1.04) | 1 (0.1) |
France 2000 (n = 19) [16] | 5 (26.3) | 6 (31.6) | 8 (42.1) | 0 |
Japan 2005 (n = 82) [42] | 30 (36.6) | 24 (29.2) | 16 (19.5) | 2 (2.4) |
France 2003 (n = 80) [43] | 34 (42.5) | 18 (22.5) | 20 (25) | 8 (10) |
Saudi Arabia 2002 (n = 20) [39] | 13 (72.2) | 2 (11.1) | 2 (11.1) | 1 (5.6) |
Italy 2010 (n = 206) [23] | 100 (48.6) | 48 (23.3) | 54 (26.2) | 4 (19.4) |
Finland 1975 (n = 86) [19] | 80 (93) | 3 (3.4) | 3 (3.4) | 0 |
| ||||
Total | 541 | 112 | 129 | 26 |